These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37767187)
21. Characterization of the Golgi scaffold protein PAQR3, and its role in tumor suppression and metabolic pathway compartmentalization. Lei L; Ling ZN; Chen XL; Hong LL; Ling ZQ Cancer Manag Res; 2020; 12():353-362. PubMed ID: 32021448 [TBL] [Abstract][Full Text] [Related]
22. Golgi scaffold protein PAQR3 as a candidate suppressor of gastric cardia adenocarcinoma via regulating TGF-β/Smad pathway. Wu YL; Hong LL; Ling ZN; Hu XY; Liu Z; Li P; Ling ZQ J Clin Lab Anal; 2022 Sep; 36(9):e24617. PubMed ID: 35870178 [TBL] [Abstract][Full Text] [Related]
23. PAQR3 modulates H3K4 trimethylation by spatial modulation of the regulatory subunits of COMPASS-like complexes in mammalian cells. Liu C; Zhang Y; Hou Y; Shen L; Li Y; Guo W; Xu D; Liu G; Zhao Z; Man K; Pan Y; Wang Z; Chen Y Biochem J; 2015 May; 467(3):415-24. PubMed ID: 25706881 [TBL] [Abstract][Full Text] [Related]
24. DDB2 is involved in ubiquitination and degradation of PAQR3 and regulates tumorigenesis of gastric cancer cells. Qiao S; Guo W; Liao L; Wang L; Wang Z; Zhang R; Xu D; Zhang Y; Pan Y; Wang Z; Chen Y Biochem J; 2015 Aug; 469(3):469-80. PubMed ID: 26205499 [TBL] [Abstract][Full Text] [Related]
25. PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells. Huang W; Guo W; You X; Pan Y; Dong Z; Jia G; Yang C; Chen Y Oncotarget; 2017 Aug; 8(33):53948-53958. PubMed ID: 28903314 [TBL] [Abstract][Full Text] [Related]
26. [Expression and Clinical Significance of Progesterone and Adiponectin Receptor Family Member 3 in Lung Cancer]. Liang X; Sun B; Han J; Zhao X; Liu Z Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):259-263. PubMed ID: 28442015 [TBL] [Abstract][Full Text] [Related]
27. PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability. Jin L; Tong L Immun Inflamm Dis; 2021 Sep; 9(3):827-839. PubMed ID: 33955706 [TBL] [Abstract][Full Text] [Related]
28. Silencing of PAQR3 suppresses extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via PI3K/AKT signaling pathway. Li H; Wang Y; Chen B; Shi J Eur J Pharmacol; 2018 Aug; 832():50-55. PubMed ID: 29787774 [TBL] [Abstract][Full Text] [Related]
29. Silencing PAQR3 protects against oxygen-glucose deprivation/reperfusion-induced neuronal apoptosis via activation of PI3K/AKT signaling in PC12 cells. Qiao S; Yang D; Li X; Li W; Zhang Y; Liu W Life Sci; 2021 Jan; 265():118806. PubMed ID: 33249098 [TBL] [Abstract][Full Text] [Related]
30. The emerging role of miR-20b in human cancer and other disorders: Pathophysiology and therapeutic implications. Khalilian S; Abedinlou H; Hussen BM; Imani SZH; Ghafouri-Fard S Front Oncol; 2022; 12():985457. PubMed ID: 36582800 [TBL] [Abstract][Full Text] [Related]
31. PAQR3 regulates Golgi vesicle fission and transport via the Gβγ-PKD signaling pathway. Hewavitharana T; Wedegaertner PB Cell Signal; 2015 Dec; 27(12):2444-51. PubMed ID: 26327583 [TBL] [Abstract][Full Text] [Related]
32. Prognostic and clinicopathologic significance of PAQR3 and VEGF-A expression in pulmonary adenocarcinoma. Shen XC; Zhan SH; Xu ST; Gu GJ Int J Clin Exp Pathol; 2020; 13(7):1676-1681. PubMed ID: 32782688 [TBL] [Abstract][Full Text] [Related]
33. PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells. Guo W; You X; Xu D; Zhang Y; Wang Z; Man K; Wang Z; Chen Y Carcinogenesis; 2016 Apr; 37(4):397-407. PubMed ID: 26905590 [TBL] [Abstract][Full Text] [Related]
34. The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis. Chen J; Wang F; Xu J; He Z; Lu Y; Wang Z Oncol Rep; 2016 Sep; 36(3):1612-8. PubMed ID: 27461225 [TBL] [Abstract][Full Text] [Related]
35. Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism. Xiao H; Sun X; Lin Z; Yang Y; Zhang M; Xu Z; Liu P; Liu Z; Huang H Acta Pharm Sin B; 2022 Jun; 12(6):2887-2904. PubMed ID: 35755276 [TBL] [Abstract][Full Text] [Related]
36. Progestin and AdipoQ Receptor 3 Upregulates Fibronectin and Intercellular Adhesion Molecule-1 in Glomerular Mesangial Cells Zou Y; Chen Z; Li J; Gong W; Zhang L; Xu F; Chen L; Liu P; Huang H Front Endocrinol (Lausanne); 2018; 9():275. PubMed ID: 29930535 [TBL] [Abstract][Full Text] [Related]
37. Aberrant promoter methylation of the PAQR3 gene is associated with prostate cancer. Lounglaithong K; Bychkov A; Sampatanukul P Pathol Res Pract; 2018 Jan; 214(1):126-129. PubMed ID: 29122400 [TBL] [Abstract][Full Text] [Related]
38. MiR-153-3p reduces extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via targeting PAQR3 in diabetic nephropathy. Yang H; Fang X; Shen Y; Yao W; Chen D; Shen L Endocrinol Diabetes Nutr (Engl Ed); 2021 Jul; ():. PubMed ID: 34247992 [TBL] [Abstract][Full Text] [Related]
39. MiR-153-3p reduces extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via targeting PAQR3 in diabetic nephropathy. Yang H; Fang X; Shen Y; Yao W; Chen D; Shen L Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):34-42. PubMed ID: 35232557 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3. Xiu Y; Liu Z; Xia S; Jin C; Yin H; Zhao W; Wu Q PLoS One; 2014; 9(10):e109734. PubMed ID: 25330156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]